In a surprising but strategic move, Windtree Therapeutics, a U.S.-listed pharmaceutical firm, has stepped into the world of cryptocurrency. As per the latest Windtree therapeutics news, the company has signed a $60 million investment deal with Build and Build Corp to launch a BNB treasury strategy.
This could go up to $200 million in total subscriptions, making it the first NASDAQ-listed company to directly hold this token.
This marks a massive shift for this company, which until now was mainly known for its biotech work. With this decision, it's not just entering crypto—it's aiming to lead in it.
Windtree's $60 million deal is just the beginning. The agreement with Build and Build Corp includes an option for up to $140 million more in future investments. That brings the total possible funding to $200 million.
These funds will be used to buy the coins, shares in Osprey its Chain Trust, and build a solid crypto treasury.
According to the official announcement on X account, this move will give the company a strong position in the fast-growing ecosystem.
Once the deal is finalized and approved by shareholders, Windtree Therapeutics will become the first public company on NASDAQ to hold tokens directly. This is a big deal.
While companies like MicroStrategy have invested in Bitcoin, this company’s strategy focuses on this exchange, the fifth-largest cryptocurrency by market cap.
It also gives investors regulated access to the Binance Smart Chain (BSC)—something that's been missing in the U.S. market. This unique offering taps into the need for secure, transparent, and compliant access to crypto assets.
This token powers the Binance Smart Chain, one of the busiest blockchains in the world. With over $2 billion in daily trading volume, BNB is the most liquid exchange token globally.
The BSC network supports thousands of DeFi apps, fast and low-cost transactions, and has millions of users, especially in Asia. By creating a BNB crypto treasury strategy, Windtree is positioning itself at the center of this expanding market, and its $WINT token has also surged after this announcement as per TradingView chart.
While the news is exciting, it’s not official just yet. The deal still needs shareholder approval and must pass certain regulatory conditions. But once that’s done, Windtree’s binance treasury will go live.
The crypto world is watching this move closely. If Windtree succeeds, other companies might follow with similar strategies, just like what happened after MicroStrategy adopted Bitcoin.
This move isn't just another investment—it’s a complete transformation. This is turning from a pharma player into a Binance investment leader, with a unique treasury backed by regulated, institutional-grade funding.
With the crypto market heating up again, this BNB treasury strategy gives the company a first-mover advantage. And for investors? It offers something new: a way to access the Binance ecosystem through a NASDAQ-listed stock.
As the Windtree therapeutics news today continues to trend, one thing is clear—this is no ordinary deal. It’s a historic entry into crypto treasuries that may redefine how Wall Street views altcoins.
Sara Sethiya is an experienced crypto journalist with five years of experience in blockchain research, price movements, and market analysis. With a background in mass communication and journalism, she specializes in data-driven news articles, in-depth market reports, and SEO-optimized content. As a team lead and content writer at CoinGabbar, she examines on-chain metrics, evaluates liquidity trends, and analyzes tokenomics to uncover market patterns. Her analytical approach helps traders and investors interpret market shifts, identify potential opportunities, and understand the broader impact of blockchain innovations on the financial ecosystem.